宮田 純

Medicine & Life Sciences

1. Asthma 100%
2. Eosinophils 75%
3. Inflammation 40%
4. Adrenal Cortex Hormones 35%
5. cysteinyl-leukotriene 35%
6. benralizumab 34%
7. Interleukin-33 25%
8. Lung 24%
9. Therapeutics 21%
10. Chronic Obstructive Pulmonary Disease 21%
11. 17,18-epoxy-5,8,11,14-eicosatetraenoic acid 20%
12. Bronchoalveolar Lavage Fluid 19%
13. Coinfection 18%
14. Tobacco Products 17%
15. Docosahexaenoic Acids 17%
16. Eicosapentaenoic Acid 17%
17. protectin D1 17%
18. Ovalbumin 17%
19. Cytokines 17%
20. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 16%
21. Non-Small Cell Lung Carcinoma 16%
22. Japan 16%
23. Interleukin-4 Receptors 16%
24. Annular Erythema 16%
25. guanidine thiocyanate 16%
26. 1-Acylglycerophosphocholine O-Acyltransferase 16%
27. Smoke 16%
28. Nanopore Sequencing 15%
29. 12-15-lipoxygenase 15%
30. Proteogenomics 15%
31. thymic stromal lymphopoietin 15%
32. S 1 (combination) 15%
33. Omega-3 Fatty Acids 15%
34. Macrophages 15%
35. resiquimod 15%
36. Sepsis 15%
37. Immunoglobulin E 14%
38. lipoxin A4 14%
39. Necrotizing Pneumonia 14%
40. Nasal Polyps 14%
41. Mucus 14%
42. pazopanib 13%
43. Tiotropium Bromide 13%
44. Annexin A1 13%
45. Toll-Like Receptor 7 13%
46. Serum 13%
47. Fatty Acids 13%
48. Nocardia Infections 13%
49. Allergic Bronchopulmonary Aspergillosis 13%
50. Thromboxane Receptors 13%